enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
9.66
-0.34 (-3.40%)
At close: Mar 3, 2026, 4:00 PM EST
9.56
-0.10 (-1.04%)
After-hours: Mar 3, 2026, 4:25 PM EST
enGene Holdings Market Cap
enGene Holdings has a market cap or net worth of $647.12 million as of March 3, 2026. Its market cap has increased by 103.11% in one year.
Market Cap
647.12M
Enterprise Value
485.18M
1-Year Change
103.11%
Ranking
Category
Stock Price
$9.66
Market Cap Chart
Since February 1, 2022, enGene Holdings's market cap has increased from $155.91M to $647.12M, an increase of 315.06%. That is a compound annual growth rate of 41.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 669.89M | 10.75% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 672.36M |
| Jade Biosciences | 640.15M |
| Vor Biopharma | 634.01M |
| Alto Neuroscience | 628.01M |
| Zura Bio | 626.18M |
| YD Bio | 613.89M |
| LB Pharmaceuticals | 610.72M |
| Ocugen | 604.95M |